- Home
- HII vs RVPHW Comparison
HII vs RVPHW Comparison
Compare HII & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HII
- RVPHW
- Stock Information
- Founded
- HII 1886
- RVPHW N/A
- Country
- HII United States
- RVPHW United States
- Employees
- HII N/A
- RVPHW 15
- Industry
- HII Marine Transportation
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- HII Industrials
- RVPHW Health Care
- Exchange
- HII Nasdaq
- RVPHW Nasdaq
- Market Cap
- HII N/A
- RVPHW N/A
- IPO Year
- HII N/A
- RVPHW 2018
- Fundamental
- Price
- HII $252.26
- RVPHW $0.11
- Analyst Decision
- HII Hold
- RVPHW
- Analyst Count
- HII 5
- RVPHW 0
- Target Price
- HII $290.00
- RVPHW N/A
- AVG Volume (30 Days)
- HII 405.6K
- RVPHW N/A
- Earning Date
- HII 10-31-2024
- RVPHW N/A
- Dividend Yield
- HII 2.07%
- RVPHW N/A
- EPS Growth
- HII 44.93
- RVPHW N/A
- EPS
- HII 18.84
- RVPHW N/A
- Revenue
- HII $11,775,000,000.00
- RVPHW N/A
- Revenue This Year
- HII $3.79
- RVPHW N/A
- Revenue Next Year
- HII $3.63
- RVPHW N/A
- P/E Ratio
- HII $13.42
- RVPHW N/A
- Revenue Growth
- HII 8.04
- RVPHW N/A
- 52 Week Low
- HII $212.58
- RVPHW N/A
- 52 Week High
- HII $299.50
- RVPHW N/A
- Technical
- Relative Strength Index (RSI)
- HII 35.37
- RVPHW N/A
- Support Level
- HII $255.38
- RVPHW N/A
- Resistance Level
- HII $259.79
- RVPHW N/A
- Average True Range (ATR)
- HII 5.13
- RVPHW 0.00
- MACD
- HII -0.70
- RVPHW 0.00
- Stochastic Oscillator
- HII 23.37
- RVPHW 0.00
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.